Author:
Hnilica L. S.,Olinski R.,Banjar Z. M.,Schmidt W. N.,Briggs R. C.
Reference22 articles.
1. B. Rosenberg, L. Van Camp, J. E. Trosko, and V. H. Mansour, Platinum compounds: a new class of potent antitumor agents, Nature, 222: 385 (1969).
2. J. M. Hill, and R. J. Speer, Organo-platinum complexes as antitumor agents (review), Anticancer Res., 2: 173 (1982).
3. A. C. M. Plooy, and P. H. M. Lohman, Platinum compounds with antitumor activity, Toxicology, 17: 169 (1980).
4. S. J. Lippard, H. M. Ushay, C. M. Merkel, and M. C. Poirier, Use of antibodies to probe the stereochemistry of antitumor platinum drug binding do deoxyribonucleic acid, Biochemistry, 22: 5165 (1983).
5. S. E. Sherman, D. Gibson, A. H. J. Wang, and S. J. Lippard, X-Ray structure of the major adduct of the anticancer drug Cisplatin with DNA: cis-[Pt(NH3)2(apGpG)], Science, 230: 412 (1985).